A growth signal with an artificially induced erythropoietin receptor-gp130 cytoplasmic domain heterodimer

Journal of Biochemistry

Volumn 130, Issue 2, 2001, Pages 305-312

  Kawahara, Masahiro ^a   Ueda, Hiroshi ^a   Tsumoto, Konhei ^b   Kumagai, Izumi ^b   Mahoney, Walt ^c   Nagamune, Teruyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Tokyo University   (Japan)

^c INVITROGEN CORPORATION   (United States)

Author keywords

Antibody variable region; Chimeric receptor; Erythropoietin receptor; Gp130; Heterodimer

Indexed keywords

DIMER; ERYTHROPOIETIN RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 3; JANUS KINASE; LYSOZYME; STAT3 PROTEIN; STAT5 PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; ANTIGENS, CD; CELL DIVISION; CELL LINE; CELL SURVIVAL; CYTOKINE RECEPTOR GP130; DIMERIZATION; MEMBRANE GLYCOPROTEINS; MICE; MURAMIDASE; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; JANUS; UEDA;

EID: 0034866350     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a002987     Document Type: Article

References (45)

1. A proliferation switch for genetically modified cells
2. Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells
3. Cell-growth control by monomeric antigen; the cell surface expression of lysozyme-specific Ig V-domains fused to truncated Epo receptor
4. Small-molecule control of insulin and PDGF receptor signaling and the role of membrane attachment
5. Three-part inventions: Intracellular signaling and induced proximity
6. Dimerization as a regulatory mechanism in signal transduction
7. A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells
8. Antigen responsive antibody-receptor kinase chimera
9. Open sandwich ELISA: A novel immunoassay based on the interchain interaction of antibody variable region
10. Molecular cloning and expression of an IL-6 signal transducer, gp130
11. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
12. The conserved box 1 motif of cytokine receptors is required for association with JAK kinases
13. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5
14. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
15. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT
16. A distinct function of STAT proteins in erythropoietin signal transduction
17. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells
18. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D
19. The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130
20. Signal transduction in the erythropoietin receptor system
21. Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo
22. Replacing factor dependency with that for lysozyme: Affordable culture of IL-6 dependent hybridoma by transfecting artificial cell surface receptor
23. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor β subunit (βIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3
24. The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor
25. Interaction of the erythropoietin and stem-cell-factor receptors
26. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation
27. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
28. Erythropoietin receptor activation by a ligand-induced conformation change
29. Efficiency of signalling through cytokine receptors depends critically on receptor orientation
30. Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 Å
31. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation
32. Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies
33. Single-molecule imaging of EGFR signalling on the surface of living cells
34. Epidermal growth factor receptor dimerization monitored in live cells
35. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: A fluorescence resonance energy transfer study
36. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines
37. The role of disulfide-linked dimerization in interleukin-3 receptor signaling and biological activity
38. L-alkaline phosphatase fusion proteins
39. Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigen
40. Open sandwich enzyme-linked immunosorbent assay for the quantitation of small haptens
41. Systematic improvement of a chemically-defined protein-free medium for hybridoma growth and monoclonal antibody production
42. Stimulating cell proliferation through the pharmacologic activation of c-kit
43. Targeted expansion of genetically modified bone marrow cells
44. Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene
45. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells